Drägerwerk AG & Co. KGaA/€DRW8
06:30
10:10
13:45
17:25
21:00
1D1W1MYTD1Y5YMAX
About Drägerwerk AG & Co. KGaA
Drägerwerk AG & Co. KGaA is a German company specializing in medical and safety technology. The company provides a range of products and solutions in the fields of critical care, which includes anesthesia workstations, ventilators, and patient monitoring, as well as safety products for personal protection, gas detection, and firefighting. Dräger was founded in 1889 and is headquartered in Lübeck, Germany. Its operations extend globally, serving various industries such as healthcare, emergency services, mining, and industrial applications. Drägerwerk's strategic strength lies in its focus on high-quality, technologically advanced products and its long-standing expertise in medical and safety technologies.
Ticker
€DRW8
Sector
Primary listing
XETRA
Employees
16,684
Headquarters
Website
DRW8 Metrics
BasicAdvanced
€1.2B
-
-
0.39
€1.97
3.23%
Price and volume
Market cap
€1.2B
Beta
0.39
52-week high
€63.00
52-week low
€37.51
Average daily volume
1.3K
Dividend rate
€1.97
Financial strength
Current ratio
1.759
Quick ratio
0.91
Long term debt to equity
15.54
Total debt to equity
24.927
Dividend payout ratio (TTM)
31.00%
Interest coverage (TTM)
9.75%
Profitability
EBITDA (TTM)
243.163
Gross margin (TTM)
45.35%
Net profit margin (TTM)
3.54%
Operating margin (TTM)
4.71%
Effective tax rate (TTM)
30.55%
Revenue per employee (TTM)
€200,000
Management effectiveness
Return on assets (TTM)
3.33%
Return on equity (TTM)
8.20%
Valuation
Dividend yield (TTM)
3.23%
Forward dividend yield
3.23%
Growth
Revenue change (TTM)
2.14%
3-year revenue growth (CAGR)
5.01%
10-year revenue growth (CAGR)
2.96%
3-year dividend per share growth (CAGR)
120.25%
10-year dividend per share growth (CAGR)
3.86%
Bulls say / Bears say
In FY 2024, Drägerwerk delivered a 16.6% increase in EBIT to €194.0 million and improved its margin to 5.8%, enabling a dividend hike to €1.97 per common share and reinforcing its cash-return policy (EQS News).
Q1 2025 saw order intake rise 6.1% year-on-year to €861 million—Dräger’s strongest first quarter since 2020—driven by robust demand across both medical and safety divisions (EQS Ad-hoc).
In H1 2025, order intake surged 10.1% to €1,738.0 million, the highest half-year level since 2020, with the Americas region up ~25% and strong contributions from both divisions, setting the stage for potential second-half sales growth (TradingView).
Q1 2025 EBIT plunged to just €0.4 million from €15.1 million a year earlier, translating into a razor-thin 0.1% margin as rising personnel and other expenses eroded profitability despite stable sales (EQS Ad-hoc).
In H1 2025, EBIT fell to €20.4 million versus €55.8 million in H1 2024, mainly due to the absence of prior-year one-off gains and negative currency and customs effects, highlighting ongoing earnings pressure at base levels (FinanzWire).
Medical division net sales declined by 3.4% in FY 2024 to €1,899.7 million (2023: €1,966.2 million) and Asia-Pacific sales fell 10.9%, underscoring regional demand weakness that could dampen future growth (FinanzWire).
Data summarised monthly by Lightyear AI. Last updated on 9 Oct 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Drägerwerk AG & Co. KGaA stock?
Drägerwerk AG & Co. KGaA (DRW8) has a market cap of €1.2B as of November 02, 2025.
What is the P/E ratio for Drägerwerk AG & Co. KGaA stock?
The price to earnings (P/E) ratio for Drägerwerk AG & Co. KGaA (DRW8) stock is 0 as of November 02, 2025.
Does Drägerwerk AG & Co. KGaA stock pay dividends?
Yes, the Drägerwerk AG & Co. KGaA (DRW8) stock pays dividends to shareholders. As of November 02, 2025, the dividend rate is €1.97 and the yield is 3.23%. Drägerwerk AG & Co. KGaA has a payout ratio of 31% on a trailing twelve-month basis.
When is the next Drägerwerk AG & Co. KGaA dividend payment date?
The next Drägerwerk AG & Co. KGaA (DRW8) dividend payment date is unconfirmed.
What is the beta indicator for Drägerwerk AG & Co. KGaA?
Drägerwerk AG & Co. KGaA (DRW8) has a beta rating of 0.39. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.